ZCMD News

The IPO market is feeling the effects of the coronavirus outbreak with a surge in the VIX volatility index weighing on IPO activity. Since 2015, a week in which VIX volatility has surpassed 35 has been followed by a week averaging two US IPO pricings. Our observational...read more

Zhongchao, a chinese internet platform providing medical information, education, and training, raised $12 million by offering 3 million shares at $4, the low end of the range of $4.00 to $4.50. Zhongchao plans to list on the Nasdaq under the symbol ZCMD. Network 1 Financial Securities acted as lead manager on the deal....read more

There are no companies scheduled to price next week, though two micro-cap IPOs may price on a day-to-day basis: Chinese healthcare training platform Zhongchao (ZCMD) and flooring roll-up F5 Finishes (FLRZ). A number of IPOs may launch on Tuesday, including preclinical gene therapy developer Passage Bio (PASG)....read more

Seven IPOs and one SPAC plan to raise $2.3 billion in the week ahead. While Casper Sleep’s (CSPR) IPO down round creates more buzz about unprofitable unicorns, institutional investors are quietly eyeing drug development services provider PPD (PPD), set to be the year’s second billion-dollar deal. They are joined by a life sciences...read more